BPMC

Blueprint Medicines
BPMC

Overview Fund Activity
Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

246 hedge funds and large institutions have $3.74B invested in Blueprint Medicines in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 84 increasing their positions, 91 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
246
Holders Change
-32
Holders Change %
-11.51%
% of All Funds
3.89%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
34
Increased
84
Reduced
91
Closed
64
Calls
$11.6M
Puts
$7.29M
Net Calls
+$4.34M
Net Calls Change
+$6.7M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$341M
2
CCM
2
Cadian Capital Management
New York
$123M
3
FCM
3
Farallon Capital Management
California
$86.7M
4
State Street
4
State Street
Massachusetts
$145M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$250M

Top Sellers

1
TCM
1
TimesSquare Capital Management
New York
$15.6M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$0
3
Marshall Wace
3
Marshall Wace
United Kingdom
$11.9M
4
APM
4
Avidity Partners Management
Texas
$18.6M
5
William Blair Investment Management
5
William Blair Investment Management
Illinois
$69.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
AAP
301
Arax Advisory Partners
Colorado
– -$1K -7 Closed
MPWT
302
MassMutual Private Wealth & Trust
Connecticut
– -$1K -6 Closed
9 10 11 12
13